A hazmat fee may apply depending on the amount ordered, as indicated in the list of package sizes.
DMSO: 21mg/mL; H2O: <1mg/mL; EtOH: <1mg/mL
Calcium channel blocker
REVIEW Manidipine dihydrochloride is a racemic, lipophilic, third-generation dihydropyridine calcium channel blocker used as an antihypertensive. It has high selectivity for the vasculature, inducing marked peripheral vasodilation with negligible cardiodepression. In addition, manidipine does not significantly affect norepinephrine levels, suggesting a lack of sympathetic activation.
Meguro, Kanji; Nagaoka, Akinobu Dihydropyridine derivatives and their use Eur. Pat. Appl. (1983), EP 94159 A1 19831116.
Meguro, Kanji; Aizawa, Masahiro; Sohda, Takashi; Kawamatsu, Yutaka; Nagaoka, Akinobu New 1,4-dihydropyridine derivatives with potent and long-lasting hypotensive effect Chemical & Pharmaceutical Bulletin (1985), 33(9), 3787-97.
Kakihana, Mitsuru; Suno, Masahiro; Nagaoka, Akinobu Antihypertensive effect of CV-4093, a new calcium antagonist, in three rat models of hypertension Japanese Journal of Pharmacology (1988), 48(2), 223-8.
Ruggenenti P, Lauria G, Iliev IP, Fassi A, Ilieva AP, Rota S, Chiurchiu C, Barlovic DP, Sghirlanzoni A, Lombardi R, Penza P, Cavaletti G, Piatti ML, Frigeni B, Filipponi M, Rubis N, Noris G, Motterlini N, Ene-Iordache B, Gaspari F, Perna A, Zaletel J, Bossi A, Dodesini AR, Trevisan R, Remuzzi G; DEMAND Study Investigators (2011). Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial. Hypertension. 58(5):776-83. PMID 21931073.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.